Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in North India

Infection, Genetics and Evolution

Volumn 9, Issue 6, 2009, Pages 1352-1355

  Mathuria, Jitendra Prasad ^a   Nath, Gopal ^a   Samaria, Jai Kumar ^a   Anupurba, Shampa ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

INH; inhA; katG; Multiplex PCR; PCR RFLP; Tuberculosis

Indexed keywords

ISONIAZID;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; INDIA; MOLECULAR GENETICS; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 70449587181     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.09.008     Document Type: Article

References (38)

1. Abate G., Hoffner S.E., Thomsen V.O., and Miorner H. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 329-333
2. Baker L.V., Brown T.J., Maxwell O., Gibson A.L., Fang Z., Yates M.D., and Drobniewski F.A. Molecular analysis of isoniazid resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC 246A polymorphism. Antimicrob. Agents Chemother. 49 (2005) 1455-1464
3. Bakonyte D., Baranauskaite A., Cicenaite J., Sosnovskaya A., and Satakenas P. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob. Agents Chemother. 47 (2003) 2009-2011
4. Banerjee A., Dubnau E., Quemard A., Balasubramanian V., Um K.S., Wilson T., Collins D., de Lisle G., and Jacobs Jr. W.R. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263 (1994) 227-230
5. Canetti G., Fox W., Khomenko A., Mahler H.T., Menon N.K., Mitchison D.A., Rist N., and Smelev N.A. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. World Health Organ. 41 (1969) 21-43
6. Caws M., Tho D.Q., Duy P.M., Lan N.T., Hoa D.V., Torok M.E., Chau T.T., Chau N.V., Chinh N.T., and Farrar J. PCR-restriction fragment length polymorphism for rapid, low-cost identification of isoniazid-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 45 (2007) 1789-1793
7. Dobner P., Rüsch-Gerdes S., Bretzel G., Felsmann K., Rifai M., Löscher T., and Hinder H. Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. Int. J. Tuberc. Lung Dis. 1 (1997) 365-369
8. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282 (1999) 677-686
9. Herrera-León L., Molina T., Saíz P., Sáez-Nieto J.A., and Jiménez M.S. New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob. Agents Chemother. 49 (2005) 144-147
10. Kiepiela P., Bishop K.S., Smith A.N., Roux L., and York D.F. Genomic mutations in the katG, inhA, and ahpC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber. Lung Dis. 80 (2000) 47-56
11. Lavender C., Globan M., Sievers A., Billman-Jacobe H., and Fyfe J. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob. Agents Chemother. 49 (2005) 4068-4074
12. Lee A.S., Lim I.H., Tang L.L., Telenti A., and Wong S.Y. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob. Agents Chemother. 43 (1999) 2087-2089
13. Lee A.S.G., Teo A.S.M., and Wong S.Y. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 45 (2001) 2157-2159
14. Leung E.T., Kam K.M., Chiu A., Ho P.L., Seto W.H., Yuen K.Y., and Yam W.C. Detection of katG Ser315Thr substitution in respiratory specimens from patients with isoniazid-resistant Mycobacterium tuberculosis using PCR-RFLP. J. Med. Microbiol. 52 (2003) 999-1003
15. Metchock B.G., Nolte F.S., and Wallace Jr. R.J. Mycobacterium. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of Clinical Microbiology. 7th ed. (1999), ASM Press, Washington, DC 399-437
16. Mokrousov I., Narvskaya O., Otten T., Limeschenko E., Steklova L., and Vyshnevskiy B. High prevalence of katG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob. Agents Chemother. 46 (2002) 1417-1424
17. Mokrousov I., Otten T., Filipenko M., Vyazovaya A., Chrapov E., Limeschenko E., Steklova L., Vyshnevskiy B., and Narvskaya O. Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele specific PCR assay targeting katG codon 315 variation. J. Clin. Microbiol. 40 (2002) 2509-2512
18. Musser J.M., Kapur D., Williams D.L., Kreiswirth B.N., Van Soolingen D., and Van Embden J.D. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid resistant and susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutation associated with drug resistance. J. Infect. Dis. 173 (1996) 196-202
19. Nachamkin I., Kang C., and Weinstein M.P. Detection of resistance to isoniazid, rifampin and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin. Infect. Dis. 24 (1997) 894-900
20. Narvskaya O., Mokrousov I., Otten T., Filipenko M., Vyazovaya A., Chrapov E., Limeschenko E., Steklova L., and Vyshnevskiy B. Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation. J. Clin. Microbiol. 40 (2002) 2509-2512
21. Park H., Song E.J., Song E.S., Lee E.Y., Kim C.M., Jeong S.H., Shin J.H., Jeong J., Kim S., Park Y.K., Bai G.H., and Chang C.L. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 44 (2006) 1619-1624
22. Piersimoni C., Olivieri A., Benacchio L., and Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated non radiometric systems. J. Clin. Microbiol. 44 (2006) 20-28
23. Ramaswamy S., and Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79 (1998) 3-29
24. Sajduda A., Brzostek A., Popławska M., Augustynowicz-Kopec E., Zwolska Z., Niemann S., Dziadek J., and Hillemann D. Molecular characterization of rifampin and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J. Clin. Microbiol. 42 (2004) 2425-2431
25. Telenti A., Honore N., Bernasconi C., March J., Ortega A., Heym B., Takiff H.E., and Cole S.T. Genotypic assessment of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35 (1997) 719-723
26. Telenti A. Genetics of drug-resistant tuberculosis. Thorax 53 (1998) 793-797
27. Temesgen Z., Satoh K., Uhl J.R., Kline B.C., and Cockerill III F.R. Use of polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis to detect a point mutation in the catalase-peroxidase gene (katG) of Mycobacterium tuberculosis. Mol. Cell Probes. 11 (1997) 59-63
28. Tracevska T., Jansone I., Broka L., Marga O., and Baumanis V. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J. Clin. Microbiol. 40 (2002) 3789-3792
29. Uhl J.R., Kline B., and Abu-Khader L. Association of two point mutation in the catalase-peroxidase (katG) gene of Mycobacterium tuberculosis with isoniazid resistance. Abstr. 95th Gen. Meet. Am. Soc. Microbiol. (1995), ASM, Washington, DC Abstr, U46, p. 125
30. Unissa A.N., Selvakumar N., Narayanan S., and Narayanan P.R. Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. Int. J. Antimicrob. Agents 31 (2008) 71-75
31. van Doorn H.R., Claas E.C., Templeton K.E., van der Zanden A.G., te Koppele Vije A., de Jong M.D., Dankert J., and Kuijper E.J. Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3′-minor groove binder-DNA probes. J. Clin. Microbiol. 41 (2003) 4630-4635
32. van Soolingen D., de Haas P.E., Hermans P.W., Groenen P.M., and van Embden J.D. Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J. Clin. Microbiol. 31 (1993) 1987-1995
33. Victor T.C., Jordaan A.M., van Rie A., van der Spuy G.D., Richardson M., van Helden P.D., and Warren R. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber. Lung Dis. 79 (1999) 343-348
34. Wei-wei J., Igor M., Gui-zhi S., Mo L., Jia-wen L., Olga N., and A-dong S. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin. Med. J. 120 (2007) 814-819
35. WHO, 2008. Global Tuberculosis Control Surveillance, Planning, Financing. (accessed 30.11.08).
36. Zaker S.B., Titov L.P., Bahrmand A.R., and Taghikhani M. Genetic mechanicm of Mycobacterium tuberculosis resistance to antituberculosis drugs, isoniazid and rifampicine. J. Dakladi Hational Akademia Sci. Belarus. 50 (2006) 92-98
37. Zakerbostanabad S., Titov L.P., and Bahrmand A.R. Frequency and molecular characterization of isoniazid resistance in katG region of MDR isolates from tuberculosis patients in southern endemic border of Iran. Infect. Genet. Evol. 8 (2008) 15-19
38. Zhang M., Yue J., Yang Y.P., Zhang H.M., Lei J.Q., Jin R.L., Zhang X.L., and Wang H.H. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 43 (2005) 5477-5482